Summary Phenolic glycolipid J (PG L-J) is a M ycobaclerium leprae-specific antigen and the antibodies to the antigen may suggest an M. leprae infection. To compare the M. leprae transmission among the populations, we compared the prevalence ofanti-PGL-I IgM antibodies among household contacts and controls between Korea and the Philippines. In Korea (prevalence of leprosy--O·04: 1000), the prevalence of anti-PGL-I antibodies were 4·8% among controls and 8·0% among contacts, respectively. On the other hand, the seroprevalence rate was 10·8% among controls and 13-4% among contacts in the Philippines (prevalence of leprosy--O·70 : 1000). Interestingly, a marked difference was noted in the prevalance of anti-PGL-I antibodies among children between the countries; 10-14% among children under 10 years old and 15-18% among those aged between 10 and 19 in the Philippines compared to 0% and 2'9-6-4% in Korea, respectively. This study, therefore suggests that a high prevalance of anti-PGL-I IgM antibodies among children may indicate an active transmission of M. leprae, resulting in a higher incidence of leprosy in the population.
The prevalence or incidence of leprosy has continuously changed in a closed population along with various factors, such as coverage of leprosy control programmes, and socioeconomic status. The recent introduction of multi drug therapy I for leprosy patients is about to bring the incidence ofleprosy down fu rther in the near future. However, it has been difficult to determine the M. /eprae transmission in the community partly due to a lack of specific tools to measure it.
A recent development ofa seroepidemiological tool based on the phenolic glycolipid T (PGL-T),2 an M. /eprae-specific antigen, made it possible to detect the M. /eprae infection or exposure to the organism.3-5 Tn the literature, the prevalence of anti-PGL-I antibodies varied from 1·0 to 16·0% among controls6-IO in the endemic areas of leprosy, and from 12 to 20% among household contacts.6-9,11 However, few studies focused on the dynamics of M. lep rae transmission among controls and contacts between countries, and correlated the prevalance of anti-PGL-I antibodies to the incidence and prevalence ofleprosy among the populations under study.
This study was thus initiated to compare the seroprevalence among household contacts and controls between Korea, where the incidence of leprosy has declined rapidly, and the Philippines, where the incidence has been stable or only gradually declining during the last two decades. The age-adjusted prevalences of anti-PGL-T IgM antibodies were then compared among household contacts and controls between the countries.
Materials and methods

STUDY POPULATIONS
Korea has been an endemic area of leprosy for several centuries; however, since the economics of the country started to improve dramatically late in the 1960s, there has been a rapid decline in the incidence of leprosy from about 1500 new cases in 19731 2 to 106 cases in 1988.13 There were about 25,000 registered cases in a population of 42 million. However, most of the registered patients are inactive and only about 1800 patients (prevalence; 0·04 : 1000) are still active, i.e. bacteriologically positive with a skin smear. When the characteristics of new patients were analysed, there was also changes in the proportion of clinical types, i.e. only 39% of new cases were lepromatous in 1973, but about 56% were lepromatous patients in 1988. Among new cases found in 1988, 72% were more than 40 years old. Only 1·0% were under 15 years old, thus indicating that Korean children now have little chance of being exposed to M. leprae. 1 3 Tn the Philippines, there were about 56,000 registered leprosy cases in a population of 55 million in 1986, and about 70% (38,000 cases) of them were active patients, i.e. BI positive (prevalence; O· 70 : 1000).14 The incidence of leprosy in the urban Manila area was 934 cases in 1978 and slightly decreased to 739 cases in 1986; however, total active cases increased from 6957 cases in 1978 to 11,727 cases in 1986. 1 4 Among the new cases, 34% were lepromatous, 27% were tuberculoid, and 38% were borderline, respectively. T nterestingly, 10· 5% of new cases were under 15 years old, and 27% were aged between 15 and 24, thus indicating that the substantial portion of new cases still occur in young age groups. In the Cebu City area, Philippines, there were 348 new cases in 1985, and the distribution of clinical types of new cases were as follows; tuberculoid 41,7%, lepromatous 30,2%, borderline 18·7';';0, and indeterminate 9'5%.1 4
SERUM SPECIMENS
Controls from Korea consisted of 244 children who visited the paediatrics clinic at a teaching hospital in Seoul, where the prevalence of active leprosy patients is about 0·03: 1000, 13 388 residents from low endemic rural areas (prevalence; 0·02 : 1000), and 500 residents who were presented for reasons other than leprosy to the Catholic Skin Disease Clinic in the Kyungbuk province, which is one of the provinces with the highest prevalance of leprosy (0,05: 1000). Serum samples were also obtained from 1151 household contacts residing in the resettlement villages scattered throughout the Kyungbuk province.
Normal controls in the Philippines also represented the heterogeneous populations consisting of 304 persons who visited the Skin Clinic of the Leonard Wood Memorial Center for Leprosy Research, Cebu City, for reasons other than leprosy and 300 persons who visited a paediatrics clinic or were blood donors or medical students in the urban Manila area. A total of 365 serum samples were from household contacts of leprosy patients in the Cebu and the Manila area.
DETECTION OF ANTIBODIES TO PGL-I
An enzyme-linked immunosorbent assay (ELISA) described by Voller et al. ls was employed with minor modification as reported previously.3. 16 However, instead of the native glycolipid, the semi-synthetic neoglycoprotein 0-( 17 was used. Briefly, 50 III of diluted ND-O-BSA (20 ng sugar/ml) in carbonate buffer, pH 9·6, was added to the wells of U-bottom microtitre plates (Dynatech Laboratories, Inc., Alexandria, VA, USA), and incubated overnight at 37°C in a moist chamber. The wells were then washed with phosphate-buffered saline (PBS) solution, pH 7·4, containing 0·05% Tween 20 (PBST) and blocked by the addition of 100 III of PBST-0·05% bovine serum albumin (BSA) at 37°C for I h. After emptying the wells, 50 III of serum diluted 1: 300 in PBST-5% normal goat serum (NGS) (Gibco Laboratories, Grand Island, NY, USA) was added to the wells which were incubated at 37°C for 90 min. After washing the wells, 50 III of affinity purified peroxidase-conjugated goat anti-human IgM (Behring Diagnostics, San Diego, CA, USA) diluted 1: 5000 in PBST-5% NGS was added and incubation was continued at 3rC for I h. After another washing, 50 III of substrate solution, H 2 0ro-phenylenedia mine was added to the wells which were incubated at room temperature for about 15 min. The reaction was then stopped with 50 III of 2·5 N H 2 S0 4 and the absorbance was read at 490 nm.
Each test was performed in triplicate and the mean absorbance of wells with BSA only was subtracted from those of wells with ND-O-BSA. Six wells in each plate were allocated for a pooled positive control serum, and plate-to-plate and day-to-day variations were adjusted based on the mean absorbance value of the positive control serum. The criteria for the seropositivity was determined by adding 2 x SD to the mean absorbance of controls, and the absorbance ;:,0·200 was considered seropositive as reported previously.8
Results
Serum specimens from controls and household contacts from Korea were examined for the presence of anti-PGL-J antibodies using ELISA. Of 1132 controls examined, 54 (4 ·8%) had significant anti-PGL-J JgM antibodies ( Table I ). The age-specific prevalance was highest among the controls (10·1 %) aged between 20 and 30 years old, and declined with increase in age. It was interesting that none of 206 controls under 10 years old and only 2·9'% of controls aged 10-19 years old were seropositive to PGL-I, thus indicating 
* Criteria for the seropositivity: IgM A490 ;;' 0·200. t Mean ± SD A490 of the seropositive individuals: 0·298 ± 0·101 (range : 0·201-0 · 708).
minimal exposure of young residents to M. leprae in Korea. The age-adjusted prevalance of anti-PGL-I IgM antibodies was a little bit higher among controls from the Kyeongbuk province (5·0%) than from another rural area (3-4%) (data not shown), thus reflecting the prevalance of leprosy cases in the rural areas of Korea.
Among the household contacts in Korea, 92 (8·0%) of the 1151 samples examined were seropositive to PG L-I ( Table 2 ). The age-specific prevalence was 0% among contacts under J 0 years old and 6-4% among contacts aged between 10 and 20 years, and was a stable 12-14% among contacts over 20 years old. The overall prevalence of anti-PGL-I IgM antibodies among contacts was significantly higher than among normal controls (p < 0·00 I, X2 test), thus indicating that household contacts in Korea had more chance of being exposed to the leprosy bacillus.
Serum samples from contacts and controls from the Philippines were also examined for the presence of anti-PGL-I IgM antibodies. The seroprevalence was lO·8% for controls (Table 3 ) and 13-4% for contacts (Table 4) , respectively. There was no significant difference in the prevalence of anti-PGL-T TgM antibodies between household contacts and controls in the Philippines, thus indicating that noncontact controls had the same chance of exposure to M. leprae as household contacts in the Philippines. The age-specific prevalence of anti-PGL-I TgM antibodies was also high with 10-14% among controls and contacts under 10 years old, and peaked at 15-18% among those aged between 10 and 19 years old, fo llowed by a gradual decline in the older age groups.
To overcome the differences in age distribution between the study populations, the age-adjusted seroprevalence of anti-PG L-I IgM antibodies was calculated based on the age structure of the populations in the Cebu Island, the Philippines. Even after adjusting for age, the prevalance of anti-PGL-I IgM antibodies was 7·4% for contacts, which was significantly higher than that among controls (4· 3%) in Korea (p < 0·0 I) (Table 5 ). In the Philippines, however, there was no significant difference in seroprevalence of anti-PGL-I antibodies between controls (I I· 3%) and contacts (13,9%), thus indicating that controls and contacts had a similar opportunity for exposure to M. ieprae. The seroprevalence among controls and contacts in the Philippines were significantly higher than those in Korea (p < 0,001, l test). More interestingly, the magnitude of the difference in seroprevalance was greater among controls and contacts under 20 years old (Table 5) . In fa ct, there was no significant difference in the prevalance of anti-PGL-I IgM antibodies among contacts and controls over 30 years old between Korea and the Philippines.
Discussion
Since PGL-I is an M. /eprae-specific antigen, the presence of antibodies to the antigen may reflect exposure to or infection with bacilli. In previous studies, the specificity of the antigen in serological tests ranged from 97 to 100'% against nonendemic controls.3-5 The cut-off values used in this study were based on the controls from the Seoul City area, where leprosy is the least prevalent in Korea, and only 1·5% of the controls exceeded the cut-off value. 8 With this critera, the seroprevalence ofanti-PGL-I JgM antibodies among household contacts and controls in the Philippines was significantly higher than those in Korea. This may reflect the higher prevalence and incidence ofleprosy in the Philippines, particularly, the higher seroprevalence among young populations, which strongly suggested that transmission has taken place widely in the community regardless of intimate contacts within the families. Interestingly, household contacts aged over 30 in Korea seemed to have a similar chance of M. /eprae infection to those in the Philippines because the seroprevalences were comparable. This may also indicate that anti-PGL-I IgM antibodies are detectable for 10-20 years or longer after exposure if no treatment is given.
Considering that a rapid decline in the incidence ofleprosy occurred during the 1970s, before the introduction of a MDT programme, the reduction of M. /eprae transmision among controls and contacts in Korea might be partly due to the improvement of the socioeconomic status and individuals' health, because Korea had a fa ster growing economy than the Philippines over the last two decades. Another possible explanation is that the segregation of leprosy patients in resettlement villages was more effective in Korea, where about half of the registered leprosy patients reside currently in over 100 resettlement villages throughout the country. 13 Interestingly, there was no significant difference in seroprevalence between contacts and controls in the Philippines, indicating that the general population was equally exposed to the leprosy bacillus. Bagshawe et af.1 also reported no significant differences in seroprevalence between controls and household contacts in Papua New Guinea. In the report, controls or contacts under 20 years old had the highest seroprevalence at 25% compared with 7% among those over 20 years of age.
One of the limitations of the PGL-I antigen for measuring the degree of M. /eprae transmission is that the sensitivity is very low (about 30-50%) among tuberculoid leprosy patients.3-5 Therefore, any prevalence rate ofanti-PGL-I IgM antibodies among controls and contacts may reflect only a portion of the individuals infected with M. leprae. Even with the limitation, however, this study suggests that the PGL-I based serology may be useful in determining the relative intensity of M. /eprae transmission among controls and contacts in populations of interest. Particularly, a high seroprevalence among children may indicate high incidence and prevalence of leprosy in the population and the active transmission of M. leprae in the community. 
SANG-NAE CHO, SEONG HWA-KIM, R V CELLONA, GERTRUDE P CHAN, T FAJARDO, G P WALSH Y JOO-DEUK KIM
Resumen EI glicolipido-I fe nolico (PGL-I) es un antigeno especifico para My cobacterium /eprae y los anticuerpos del antigeno sugieren una infeccion de M. leprae. Para comparar la transmision de M. leprae entre diferentes populaciones, comparamos el predominio de anticuerpos IgM antiPGL-I entre los contactos de domicilio y controles, entre Korea y las Filipinas. En Korea (con incidencia de lepra de 0,04 por mil), el predominio de anticuerpos antiPGL-I era 4,8% en los controles y 8,0% en los contact os respectivamente. De otro lado, la seroincidencia en las Filipinas fue 10,8% en los controles y 13,4% en los contactos (con incidencia de lepra de 0,70 por mil). Es interesante que hay una diferencia notable en el predominio de anticuerpos antiPGL-I entre los ninos de los dos paises: 10 a 14% de los ninos de menos de 10 anos de edad y 15 a 18% de los entre lOy 19 anos en la Filipinas, comparado-con 0% y 2,9 a 6,4% en Korea, respectivamente. Por 10 tanto, este estudio sugiero que el predominio mas elevado de anticuerpos IgM antiPGL en los ninos puede indicar una transmision activa de M. /eprae que resulta en una incidencia de lepra mas elevada en la populacion.
